HomeNewsBusinessEconomyExplained | Q2 GDP: Does manufacturing data flatter to deceive?

Explained | Q2 GDP: Does manufacturing data flatter to deceive?

One of the most crucial input data points used in GDP and GVA calculations is the Index of Industrial Production (IIP). IIP contracted by 10.4 per cent in July year-on-year, by 8 per cent in August and expanded by 0.2 per cent in September. So, in a quarter where IIP contracted during two months and barely rose in month, manufacturing GVA showed positive growth.

December 01, 2020 / 16:33 IST
Story continues below Advertisement

Perhaps the biggest surprise in the July-September gross domestic product data, which was released on November 27, was manufacturing gross value added (GVA).

From crashing by 39.3 percent in the April-June quarter (the quarter of nationwide lockdown), real manufacturing GVA rose 0.6 per cent in the second quarter of FY2020-21. In absolute terms, manufacturing GVA rose nearly 65 percent to Rs 5.79 lakh crore from Rs 3.51 lakh crore in April-June.

Story continues below Advertisement

More surprisingly though, in absolute terms, manufacturing GVA in the second quarter of 2018-19 (two years ago) was also Rs 5.79 lakh crore, official data by the National Statistical Office shows. In other words, is manufacturing activity and output in the time of Covid-19 pandemic same as what it was two years ago?

One of the most crucial input data points used in GDP and GVA calculations is the Index of Industrial Production (IIP). IIP contracted by 10.4 percent in July year-on-year, by 8 percent in August and expanded by 0.2 per cent in September. So, in a quarter where IIP contracted for two months and barely rose in the month, manufacturing GVA showed positive growth.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show